BioNTech SE ADR (NASDAQ:BNTX)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - BNTX
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - BNTX
- Market Cap$3.036bn
- SymbolNASDAQ:BNTX
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS09075V1026
Company Profile
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
Latest BNTX news
Currently there for this company. Visit our news hub for other news .